SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

2 Oct 2017 07:32

RNS Number : 3676S
Numis Corporation PLC
02 October 2017
 

2nd October 2017

Numis Corporation Plc

Trading Update

 

Monday 2nd October 2017 at 7.00am: Numis Corporation Plc ("Numis") today issued a trading update relating to the year ended 30th September 2017.

 

Our second half trading performance was very strong and recorded revenue 47% higher than the first half of 2017 and 38% higher than the second half of 2016. Consequently, full year revenue has grown by 15% versus prior year, and it is anticipated that profit will show similar levels of growth.

 

Our Corporate Broking & Advisory business ("CB&A") completed 98 transactions in total (2016: 86) which included equity fund raises totalling £2.5 billion, up 38% on prior year (2016: £1.8 billion). Revenue from CB&A activities has grown by 15% versus prior year.

 

Our Equities business performed well. Against a background of generally positive equity markets, combined institutional commission and trading revenues increased by 15% year-on-year. We continue to work closely with our institutional clients and believe the firm is well positioned as the implementation of MiFID II draws closer.

 

Numis will announce full preliminary results for the year ended 30th September 2017 on Wednesday 6th December 2017.

 

 

Alex Ham and Ross Mitchinson, Co-Chief Executive Officers, said:

 

"We are pleased to report that the second half was our best on record in terms of both revenue and operating profit. In addition, we have increased our focus on supporting unquoted companies and playing a key role in developing the capital markets which support them.

 

Our deal pipeline is strong and we remain determined to support ambitious companies of all sizes seeking capital and high quality advice to grow, whilst simultaneously investing in our people, platform and relationships. Whilst we cannot predict the direction of the market or the health of the equity issuance environment, there is good momentum in the business and we look forward to the future with confidence."

 

ENDS

 

 

Contacts

Numis Corporation:

Alex Ham & Ross Mitchinson 020 7260 1245

Co-Chief Executive Officers

 

 Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Samantha Harrison 020 77865 2411Harrison J Clarke 020 7184 4384 

 

 

 

 

 

 

Notes for Editors

Numis is a leading independent corporate advisory and stockbroking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUUNRBKARRRA
Date   Source Headline
28th Mar 20223:59 pmRNSTransaction in Own Shares & Total Voting Rights
24th Mar 20223:48 pmRNSTransaction in Own Shares & Total Voting Rights
22nd Mar 20224:09 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20223:43 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 202210:18 amRNSNotification of Major Holdings
17th Mar 20229:31 amRNSTransaction in Own Shares & Total Voting Rights
11th Mar 20223:36 pmRNSTransaction in Own Shares & Total Voting Rights
7th Mar 20224:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th Feb 20225:02 pmRNSTransaction in Own Shares & Total Voting Rights
24th Feb 20227:00 amRNSBoard Change – Appointment of Independent NED
22nd Feb 20222:35 pmRNSTransaction in Own Shares & Total Voting Rights
10th Feb 202210:03 amRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20221:13 pmRNSBoard Change
8th Feb 20221:12 pmRNS2022 Annual General Meeting ('AGM')
8th Feb 20227:00 amRNSAGM Trading Statement
7th Feb 20229:39 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20224:14 pmRNSHolding(s) in Company
1st Feb 20224:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20224:00 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20221:00 pmRNSDirectors’ Dealing
19th Jan 20227:00 amRNSGrant of awards under 2021 LTIP
14th Jan 20223:53 pmRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20224:27 pmRNSTransaction in Own Shares and Total Voting RIghts
5th Jan 20227:00 amRNSAppointment of General Counsel & Company Secretary
4th Jan 20223:21 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20214:53 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20214:33 pmRNSTransaction in Own Shares and Total Voting Rights
21st Dec 20215:04 pmRNSTransaction in Own Shares and Total Voting Rights
20th Dec 20212:30 pmRNSAnnual Report and AGM Notice
20th Dec 202112:29 pmRNSReplacement Director's Dealing
20th Dec 202112:09 pmRNSHolding(s) in Company
17th Dec 202112:31 pmRNSDirector’s Dealing
15th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSFull Year Results for the year ended 30 Sep 2021
29th Nov 20214:58 pmRNSNotice of Final Results for the year ended 30 Sep
18th Nov 20214:03 pmRNSHolding(s) in Company
30th Sep 202112:32 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSTrading Update
17th Sep 20214:25 pmRNSTR-1: Notification of major holdings
13th Sep 20216:29 pmRNSTR-1: Notification of major holdings
13th Sep 20216:27 pmRNSTR-1: Notification of major holdings
13th Sep 202112:54 pmRNSTR-1: Notification of major holdings
13th Sep 202112:50 pmRNSTR-1: Notification of major holdings
1st Sep 20217:00 amRNSChange of Registered Office
10th Aug 20217:00 amRNSBoard Change
29th Jul 20216:07 pmRNSTR-1: Notification of major holdings
14th Jul 20217:00 amRNSTrading Update
14th May 20217:00 amEQSEdison Investment Research Limited: Numis Corporation (NUM): Very strong results, consistent strategy
7th May 20217:00 amRNSHalf Year Results
23rd Apr 20214:24 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.